Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Corebridge Financial Inc.

Corebridge Financial Inc. trimmed its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 7.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,294 shares of the company’s stock after selling 726 shares during the quarter. Corebridge Financial Inc.’s holdings in Addus HomeCare were worth $1,165,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. American Century Companies Inc. raised its position in Addus HomeCare by 695.8% during the fourth quarter. American Century Companies Inc. now owns 284,346 shares of the company’s stock worth $35,643,000 after acquiring an additional 248,613 shares during the period. TimesSquare Capital Management LLC raised its holdings in shares of Addus HomeCare by 28.5% during the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock worth $44,593,000 after acquiring an additional 78,835 shares during the period. Principal Financial Group Inc. grew its holdings in shares of Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after purchasing an additional 75,409 shares during the period. Raymond James Financial Inc. purchased a new position in Addus HomeCare during the fourth quarter worth about $6,637,000. Finally, Boston Partners increased its holdings in shares of Addus HomeCare by 41.7% during the 4th quarter. Boston Partners now owns 173,697 shares of the company’s stock worth $22,032,000 after buying an additional 51,116 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on ADUS shares. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Oppenheimer increased their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. JMP Securities started coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price on the stock. Macquarie restated an “outperform” rating and issued a $129.00 price target on shares of Addus HomeCare in a research note on Thursday, February 27th. Finally, Stephens reiterated an “overweight” rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $132.78.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $100.31 on Friday. Addus HomeCare Co. has a 1-year low of $87.88 and a 1-year high of $136.72. The firm has a 50-day moving average of $105.09 and a two-hundred day moving average of $119.69. The stock has a market cap of $1.82 billion, a P/E ratio of 22.95, a PEG ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. As a group, equities analysts expect that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.